555 related articles for article (PubMed ID: 30496290)
1. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability.
Jadaliha M; Gholamalamdari O; Tang W; Zhang Y; Petracovici A; Hao Q; Tariq A; Kim TG; Holton SE; Singh DK; Li XL; Freier SM; Ambs S; Bhargava R; Lal A; Prasanth SG; Ma J; Prasanth KV
PLoS Genet; 2018 Nov; 14(11):e1007802. PubMed ID: 30496290
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.
Jiang B; Liu Q; Gai J; Guan J; Li Q
Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129
[TBL] [Abstract][Full Text] [Related]
3. EPHA2 antisense RNA modulates EPHA2 mRNA levels in basal-like/triple-negative breast cancer cells.
Okuyama T; Sakamoto R; Kumagai K; Nishizawa M; Kimura T; Sugie T; Kimura T
Biochimie; 2020 Dec; 179():169-180. PubMed ID: 33022313
[TBL] [Abstract][Full Text] [Related]
4. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
6. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
Luo N; Zhang K; Li X; Hu Y
J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-mediated regulation of
Tariq A; Hao Q; Sun Q; Singh DK; Jadaliha M; Zhang Y; Chetlangia N; Ma J; Holton SE; Bhargava R; Lal A; Prasanth SG; Prasanth KV
RNA; 2020 Feb; 26(2):175-185. PubMed ID: 31690584
[TBL] [Abstract][Full Text] [Related]
8. The role of long noncoding RNAs in patients with Luminal A invasive breast ductal carcinoma.
Eshghifar N; Rouhollah F; Barikrow N; Pouresmaeili F; Taheri M
Pathol Res Pract; 2021 Nov; 227():153645. PubMed ID: 34678601
[TBL] [Abstract][Full Text] [Related]
9. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
Cuesta R; Holz MK
Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
[TBL] [Abstract][Full Text] [Related]
10. lncRNA PDCD4-AS1 Promotes the Progression of Glioma by Regulating miR-30b-3p/METTL7B Signaling.
Li Z; Song Y; Zhang J
Oxid Med Cell Longev; 2023; 2023():3492480. PubMed ID: 37151605
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
12. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
[TBL] [Abstract][Full Text] [Related]
13. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
[TBL] [Abstract][Full Text] [Related]
14. Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity.
Jin YY; Andrade J; Wickstrom E
PLoS One; 2015; 10(12):e0142574. PubMed ID: 26629823
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q
Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis.
Liu X; Song J; Kang Y; Wang Y; Chen A
J Cell Biochem; 2020 Nov; 121(11):4601-4611. PubMed ID: 32277517
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NR2F2-AS1 functions as a tumor suppressor in gastric cancer through targeting miR-320b/PDCD4 pathway.
Luo M; Deng S; Han T; Ou Y; Hu Y
Histol Histopathol; 2022 Jun; 37(6):575-585. PubMed ID: 35048354
[TBL] [Abstract][Full Text] [Related]
18. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
20. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]